Skip to content
‹ Back to IndustriesSciences

The Life of a Scope

Sam Harrison, a Senior Clinical Educator at Censis Technologies, discussed the lifecycle of a scope and how Censis's tools, ScopeTrac and CensiTrac, are essential. The tools aid in the deamination, cleaning, disinfecting, and storage tracking processes, and ensure compliance with regulations.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from Censis on MarketScale.

By Sciences · · CensitracEndoscope ReprocessorScope TechnologyScopes
Share

Key takeaways

01

Scopes go through deamination before entering the OR.

02

CensiTrac tracks and documents cleaning and reprocessing procedures.

03

ScopeTrac helps comply with regulatory requirements and enhance tracking capabilities.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Sam Harrison, Senior Clinical Educator at Censis Technologies, provided Tyler Kern with an education in endoscopy when he guided him through the lifecycle of a scope and how Censis technologies’ ScopeTrac and CensiTrac play a vital role in the process.

Scopes first go through a deamination process before they enter the OR. CensiTrac then captures the cleaning and reprocessing procedures.

“When the tech checks that scope into the scope processing module, the instructions for use are displayed,” Harrison said. “Those instructions for use can be customized per the scope model, the manufacturer’s IFUs can be uploaded, or video can be uploaded to make it as easy as possible for the end-user.”

After the scope receives reprocessing, it goes to a cleaning room for disinfecting. This process requires tracking, which CensiTrac streamlines. Once disinfected and logged, a scope will go to a clean storage area, and CensiTrac will provide information on those scope’s storage location.

Once a scope enters the procedure room, CensiTrac’s case-tracking module can associate that scope to a patient through a case ID#. “In each area, CensiTrac is used to track and document every required process,” Harrison said.

ScopeTrac is another critical piece of the digital scope record process that makes it easy to comply with regulations.

“Having those processing steps there to help abide by the regulatory requirements is huge,” Harrison said. And, with the added functionality of video and image uploads, techs have additional tools and resources at their disposal to correctly identify and log in scopes.

While ScopeTrac with CensiTrac addresses all these needs, Harrison mentioned that there is now ScopeTrac Advanced, which provides additional solutions, such as OR scheduler interface capabilities.

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Censis

Part of this channel

Censis

Surgical instrument management software for over 1,300 U.S. hospitals.

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Agilent's new 5987A GC/MS takes aim at costly sample reruns

Agilent's new 5987A GC/MS takes aim at costly sample reruns

Agilent’s 5987A GC/MSD adds vendor-claimed up to 25% faster scanning and a wider detector range alongside GC Assist diagnostics tracking 60-plus parameters. Its design focuses on taking injections out of workflows to limit reruns. With helium spot prices reportedly doubling after the March 2026 disruption, avoided reruns can save gas, but EPA criteria checks and ISO/IEC 17025 verification still come first.

  • 01Injection-cutting features can matter most: MassHunter’s simultaneous dSIM/Scan to combine SIM quantitation and library-searchable full scan in one run, and Agilent’s claim of an order-of-magnitude wider dynamic range that could reduce dilution reinjections if it holds up in routine use.
  • 02Onboard diagnostics pay back unevenly. Labs that find faults by failing QC batches stand to gain the most, while labs on comprehensive service contracts may mainly change which contract tier they buy.
  • 03The up-to-40% energy cut applies with the IDP-4 pump, so bid scoring should confirm the quoted configuration before crediting the savings.

Nov 10, 2026

Adding Genmab's petosemtamab to Keytruda cut head and neck cancer death risk in half

Adding Genmab's petosemtamab to Keytruda cut head and neck cancer death risk in half

Genmab's petosemtamab, added to Merck's Keytruda, cut the risk of death by 50% in 699 first-line head and neck cancer patients. The trial held regardless of HPV status. Full data will be presented at an upcoming medical meeting.

  • 01In a cancer where median survival runs about 10 to 12 months, adding petosemtamab to Keytruda halved the risk of death at the first interim look.
  • 02The benefit held regardless of HPV status, supporting use in PD-L1-positive patients without separating by HPV status.
  • 03The figure to watch at the full-data presentation is median overall survival in each arm, because the topline release reports only the hazard ratio.

Nov 9, 2026

UCB commits to Veeva Vault CRM platform

UCB commits to Veeva Vault CRM platform

UCB has committed to Veeva Vault CRM, which Veeva’s release presents as an agentic CRM platform to drive unified engagement worldwide. UCB and Veeva executives describe it as a stable foundation for UCB’s commercial strategy, while the AI claims, including the Agentic Call Report, come from Veeva’s product description. No go-live date or financial terms were given.

  • 01The executive statements focus on Vault CRM as a foundation. The AI pitch, including the Agentic Call Report, comes from Veeva’s product description.
  • 02Veeva says the Agentic Call Report turns field call records into "Commercial Evidence" about treatment barriers that went unseen before. If it works as described, call reports gain value when analyzed at scale.
  • 03No go-live date or financial terms were disclosed. A go-live date or first-market rollout from UCB would show whether a worldwide migration is moving.

Nov 7, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

Senior Clinical Educator at Censis Technologies

Sam Harrison guides the education in endoscopy and the lifecycle of scopes at Censis Technologies. He explains how ScopeTrac and CensiTrac play vital roles in the process. He ensures compliance with regulatory requirements and streamlines the processes from cleaning to patient tracking.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512